← Back to Clinical Trials
Recruiting Phase 1 NCT06884098
A Study to Compare PK Characteristics and Safety Profiles Between AD-228B and AD-2284
Trial Parameters
Condition Primary Hypercholesterolaemia
Sponsor Addpharma Inc.
Study Type INTERVENTIONAL
Phase Phase 1
Enrollment 60
Sex ALL
Min Age 19 Years
Max Age N/A
Start Date 2025-03-10
Completion 2025-04
Interventions
AD-228BAD-2284
Brief Summary
Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of AD-228B in healthy subjects.
Eligibility Criteria
Inclusion Criteria: * Body weight equal to or greater than 50kg (Female 45kg) and Body mass index (BMI) between 18.0 kg/m2 and 30.0 kg/m2 at the time of screening visit * The Age equal to or greater than 19 in healthy volunteers at the time of screening visit Exclusion Criteria: * Participation in other clinical study with an investigational drug within the 6 months from scheduled first administration * Other exclusions applied